GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (SHSE:688366) » Definitions » EV-to-FCF

Shanghai Haohai Biological Technology Co (SHSE:688366) EV-to-FCF : 123.52 (As of Jan. 18, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Haohai Biological Technology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Haohai Biological Technology Co's Enterprise Value is ¥10,086 Mil. Shanghai Haohai Biological Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was ¥82 Mil. Therefore, Shanghai Haohai Biological Technology Co's EV-to-FCF for today is 123.52.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's EV-to-FCF or its related term are showing as below:

SHSE:688366' s EV-to-FCF Range Over the Past 10 Years
Min: -1327.58   Med: 30.23   Max: 129.39
Current: 123.05

During the past 10 years, the highest EV-to-FCF of Shanghai Haohai Biological Technology Co was 129.39. The lowest was -1327.58. And the median was 30.23.

SHSE:688366's EV-to-FCF is ranked worse than
91.14% of 395 companies
in the Biotechnology industry
Industry Median: 7.5 vs SHSE:688366: 123.05

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-01-18), Shanghai Haohai Biological Technology Co's stock price is ¥57.98. Shanghai Haohai Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥1.827. Therefore, Shanghai Haohai Biological Technology Co's PE Ratio (TTM) for today is 31.74.


Shanghai Haohai Biological Technology Co EV-to-FCF Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co EV-to-FCF Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -90.37 64.87 70.38 -43.22 11.82

Shanghai Haohai Biological Technology Co Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.25 11.82 -1,132.10 98.39 -

Competitive Comparison of Shanghai Haohai Biological Technology Co's EV-to-FCF

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's EV-to-FCF falls into.



Shanghai Haohai Biological Technology Co EV-to-FCF Calculation

Shanghai Haohai Biological Technology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=10086.212/81.656
=123.52

Shanghai Haohai Biological Technology Co's current Enterprise Value is ¥10,086 Mil.
Shanghai Haohai Biological Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haohai Biological Technology Co  (SHSE:688366) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shanghai Haohai Biological Technology Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=57.98/1.827
=31.74

Shanghai Haohai Biological Technology Co's share price for today is ¥57.98.
Shanghai Haohai Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.827.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shanghai Haohai Biological Technology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Executives
Du Peng Core technical personnel
Hou Yong Tai Director, core technical staff
Jiang Li Xia Core technical personnel
Core technical personnel
Liu Lu Core technical personnel
Ren Cai Xia senior management
Wang Wen Bin Senior management, core technical personnel
Tang Min Jie Directors, senior managers
Wu Jian Ying Directors, senior managers
Liu Yuan Zhong Supervisors
Huang Ming Director
Zhang Jun Dong Senior management, core technical personnel
You Jie Director
Tian Min senior management
Chen Yi Yi Director

Shanghai Haohai Biological Technology Co Headlines

No Headlines